Publications by authors named "G Claesson"

Claim this Profile
L
Long-term health-related quality of life in children with lymphatic malformations treated with sclerotherapy generally matched age-appropriate standardised population norms.
Nader Ghaffarpour, Gösta Claesson, Tomas Wester, Krister K Boman

Acta Paediatr· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR4 preconditioning is associated with low success of OK-432 treatment for lymphatic malformations in children.
Marc Reismann, Nader Ghaffarpour, Ethel Luvall, Adan Jirmo, Josephine Radtke, Gösta Claesson

Pediatr Surg Int· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
N Ghaffarpour, B Petrini, L A Svensson, K Boman, T Wester, G Claesson

Acta Paediatr· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic Toll-like receptor expression predicts outcome of sclerotherapy for lymphatic malformations with OK-432 in children.
Marc Reismann, Nader Ghaffarpour, Ethel Luvall, Adan C Jirmo, Ola Winqvist, Gösta Claesson

J Surg Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nerve dysfunction following surgical treatment of cervical non-tuberculous mycobacterial lymphadenitis in children.
Gösta Claesson, Rutger Bennet, Margareta Eriksson, Björn Petrini

Acta Paediatr· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis